Senior/Executive Medical Director, Clinical Development (New Indications)

What this role involves

Alumis is seeking an experienced Senior/Executive Medical Director to lead clinical development strategy and execution for Phase 1 and Phase 2 studies in neurology and new indications, focusing on a CNS-penetrant TYK2 inhibitor. The role involves designing and overseeing clinical studies, regulatory interactions, and external engagement with investigators and KOLs. The position requires an MD and offers an opportunity to shape the company's expanding clinical portfolio.

Skills this posting asks for

• clinical development
• phase 1 studies
• phase 2 studies
• neurology
• neuroinflammatory diseases
• neurodegenerative diseases
• tyk2 inhibitor
• medical monitoring
• regulatory submissions
• fda interactions
• biomarker strategies
• translational medicine

Requirements

• Level: senior

From the employer’s posting

Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamental…